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SRY by selfish alleles at other loci. A specific
candidate is the so-called ‘feminizing X’
allele found in various rodents [2]. Feminiz-
ing X alleles cause XY individuals to develop
as females, thereby gaining an advantage
through an ingenious strategy: in crosses
with standard XY males, feminized XY
females produce one-fourth nonviable YY
progeny, leading to two-thirds of surviving
progeny inheriting the feminizing X allele
[2]. Suppression of the ancestral SRY
masculinizing function could have se-
lected for acquisition of the novel spong-
ing poly-CAG region, despite the costs
of the coincidentally acquired destabilizing
degron region.
The extent to which intragenomic conflict
drives the evolution of seemingly costly
traits, such as the degron of SRY, remains
an open question. In addition to the Aristote-
lian–Darwinian presumption that biological
features exist because they enhance the
function (or fitness) of the individual, it has
increasingly been appreciated that other
features may arise or persist because se-
lection is simply too weak to effectively op-
pose them [9]. Intragenomic conflict offers
a third possibility: namely, that a feature at
one locus may be beneficial despite some
costs if it also helps the locus to escape
manipulation by selfish alleles at another
locus. A particularly promising avenue for in-
vestigation is considering the wealth of ro-
dent novelties of sex determination in the
context of potentially age-old arms
races between feminizing X alleles and re-
pressed Y chromosomes, consistent
with the notion that intragenomic conflict
may have important roles in the origins
of novel genetic systems [10].
Miyawaki et al. have broken new ground
in our understanding of the diversity and
function of the ancient mammalian sex
determination system. The past years have
seen an explosion of information on the
genetic sex determination mechanisms
of animals, plants, and fungi, and it will be
fascinating to learn more about the alterna-
tive forms and mechanisms of action of
these crucial genes.
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Despite Africa’s central role in the
origin of our species, our knowledge
of the genomic diversity in Africa is
remarkably sparse. A recent publi-
cation by Choudhury et al. under-
scores the scientific imperative
for a broader characterisation of
African genomic diversity to better
understand demographic history
and improve global human health.
Human populations are known to harbour
the greatest genetic diversity in Africa, from
where modern humans originated. There-
fore, studying genomic patterns of diversity
in Africa presents remarkable opportunities
to gain a better understanding about our
deep population history and the underlying
genetic basis of human adaptation and dis-
ease [1]. However, in comparison to popula-
tions of European or Asian ancestry,
African populations are largely under-
represented in genomic research, exac-
erbating health inequalities [2]. Heavily bi-
ased genetic databases often lead
scientists and medical doctors to diag-
nose conditions or prescribe treatments
that might be relevant to people with
European ancestry, but not for people
from other genetic backgrounds. To investi-
gate the genomic diversity across the
African continent, a recent paper by
Choudhury et al. [3] analysed whole-
genome sequencing data of 426 individuals
representing 50 ethnolinguistic groups in
Africa (Figure 1). This ground-breaking
study represents an important step in ad-
dressing existing biases in available data
for genetic research, which hamper the
study of human health problems in popula-
tions from Africa and the African Diaspora.
The study was led by the Human Heredity
and Health in Africa (H3Africa) Consortiumi
[4], funded by the US National Institutes
of Health (NIH) and the Wellcome Sanger
Institute, to redress the long-standing
scarcity of genomic research in African
populations and to support African institu-
tions conducting genomic research. The
high coverage of the newly available
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Figure 1. Geographical
Locations of African
Populations Included in
the Human Heredity
and Health in Africa
(H3Africa) Dataset De-
scribed by Choudhury
et al. [3] and from Pub-
licly Available Data. Dots
are proportional to sample
sizes of populations. Red
dots show African popula-
tions included in the 1000
Genomes Project Phase 3.
The map shows the distri-
bution of frequencies for
the APOL1 risk genotype
in Africa that were esti-
mated by Choudhury et al.
[3]. Geographical gradients
were estimated here using
the Kriging method and on
the basis of cumulative fre-
quencies of APOL1* geno-
types (G1 homozygotes,
G2 homozygotes, or G1G2
heterozygotes).
African genomes (with an average depth of
coverage between 10x and 30x) allowed
the authors to better examine rare genetic
variants in an accurate and quantifiable
way. Choudhury et al. [3] uncovered more
than three million novel variants, mostly
found in newly sampled ethnolinguistic
groups from Botswana and Mali (over 18
700 and 13 300 novel variants per individual,
respectively) and identified 33 loci with
strong evidence of selection that have not
been reported previously in African [5] or
world-wide populations [6]. As expected,
the results reflected the long history and
rich genomic diversity across the conti-
nent and further evidenced the enormous
scope for identifying novel variants in fu-
ture genomic studies in Africa.
This is one of the largest studies of high-
depth-sequenced African genomes re-
ported to date, and samples were analysed
from 13 African countries (Figure 1); how-
ever, coverage remains notably
incomplete in some African regions. Cer-
tain ethnolinguistic groups that are crucial
for population history inferences were not
included in this study, such as hunter–
gatherer groups, whose genetic heritage
represents early (prefarming) African history,
due to their deep continuities in their respec-
tive regions. This poses an important limita-
tion for producing accurate inferences
regarding deep population history and his-
torical massmigration in Africa and future re-
search will need to include more
geographically and linguistically diverse pop-
ulations to be able to test different hypothe-
ses. For instance, Southern African hunter–
gatherers (San) and herders (Khoekhoe),
known collectively as Khoe-San speaking
people, have more genomic diversity than
other African and non-African groups and
represent the deepest population diver-
gence within Homo sapiens, supported by
a recent study [7] of high-coverage whole-
genomes of five Khoe-San populations
(with an average depth of coverage 50x).
Likewise, hunter–gatherer groups from the
Central African rainforest and East Africa
are other crucial populations to include in fu-
ture genomic studies [8].
Long-distance migrations played a pivotal
role in shaping the genomic landscape in
the African continent, particularly migrations
of people speaking Bantu languages. The
broad dispersion of Bantu-speaking people
has been ascribed to a series of migrations
across sub-Saharan Africa over the past
5000 years, supported by genome-wide
studies [9,10]. Choudhury et al. [3] observed
complex genomic patterns of ancestral
mixing within and between populations and
suggested that Zambia was a likely interme-
diate site along the routes of expansion of
Bantu-speaking populations to both East
and South Africa. However, these findings
need to be interpreted with caution and
more Bantu-speaking populations
representing South, East, and Central
Africa will be needed to confirm and refine
these findings, as well as the use of
haplotype-based methods, model-testing
approaches, and well-defined hypothesis-
driven research. The Bantu-expansion
was likely a complex movement of multiple
waves of populations interacting with and
replacing each other [1] and fine-scale
data from modern and ancient individuals
across sub-Saharan Africa will be crucial
to disentangle the complex history behind
this huge expansion.
In order to generalise the discoveries from
genetic studies of complex diseases and
to provide opportunities for new under-
standing of disease aetiology and potential
therapeutic strategies, it is crucial to inves-
tigate genetic variation in world-wide pop-
ulations, particularly in non-European
populations. The study by Choudhury
et al. [3] contributes significantly to an
increasingly global context of medically
relevant genetic variation and uncovers the
genomic landscape of loci associated with
chronic noncommunicable diseases in
Africa (e.g., cardiometabolic diseases).
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Furthermore, it facilitates future studies
exploring the relevance of genetic variants
in disease burden among the African
populations. An example is the APOL1
variants (Figure 1) that provide protection
against specific Trypanosoma species in
African populations from endemic re-
gions like West Africa, but also increase
susceptibility to nephropathy in popula-
tions from non-trypanosomiasis endemic
areas in Africa or from the African Diaspora.
The study also identifies new evidence for
natural selection in 62 genes associated
with immune-related functions (for viral
and bacterial infection), involved in DNA
maintenance and carbohydrate and lipid
metabolism. The researchers additionally
teased out signals of selection within
each population, for example, genes
involved in metabolism were under selec-
tion among individuals from Botswana.
Among the selection signals detected
in Botswana, the authors also found evi-
dence for preferential gene-flow from
Khoe-San ancestry, highlighting adaptive
introgression in Southern Africa.
The study presented by Choudhury et al.
[3] is also a major milestone in African
genomics research capacity, as it was led
predominantly by local researchers using
local infrastructure and resources for
large-scale genomics research in Africa.
Collectively, their results refine our current
understanding of human migration, pat-
terns of admixture, and strong drivers of
selection across the African continent.
The study also points out the extent of
uncatalogued genomic variation across
the continent and the need for future
genomic studies of the many diverse
under-represented populations in Africa.
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Genetics and COVID-19:
How to Protect
the Susceptible
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Along with the potential for break-
throughs in care and prevention,
the search for genetic mechanisms
underlying the spread and severity
of coronavirus disease 2019 (COVID-
19) introduces the risk of discrimina-
tion against those found to have
markers for susceptibility. We pro-
pose new legal protections to miti-
gate gaps in protections under
existing laws.
Genetic research holds the promise of
unlocking secrets of COVID-19 and
opening new avenues for mitigation [1].
Among suggestive findings to date is a
possible correlation between disease
severity and DNA polymorphisms in the
virus host factors ACE2 and TMPRSS2
[2]. Findings on genetic correlates of
COVID-19 progression may lead to better
understanding of the cellular mechanisms
of susceptibility and resistance and may
enable predictions of individual risk for
severe disease progression.
Discrimination Risks
However, such advances come with a
significant social risk in the potential for
a new form of discrimination. Until a vac-
cine or effective treatment is available,
those whose genomes make them espe-
cially vulnerable might be considered
ill-suited for exposure-prone jobs, especially
in health care. They might also face resis-
tance in other spheres, such as health-
related insurance, apartment leases,
nursing home placements, and even
bank loans. Conversely, those found to
have genetic resistance may be treated
more favorably in these regards.
Governments would also face incentives
to favor those with genetic resistance to
COVID-19 in disease mitigation strate-
gies. ‘Genetic passports’ exempting ge-
netically resistant individuals from strict
social distancing restrictions would en-
able states to avoid more widespread
lockdowns. Those with genetic markers
for susceptibility would face stronger
restrictions.
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